Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.0K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.0K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SARM1 base-exchange inhibitors induce SARM1 activation and neurodegeneration at low doses.

npj drug discovery·2026
Same author

Exploring the chemical space of pharmaceutical extractables and leachables.

Regulatory toxicology and pharmacology : RTP·2026
Same author

Application of read-across to data-poor N-nitrosamines: N-nitroso-ulifloxacin, a case study.

Regulatory toxicology and pharmacology : RTP·2026
Same author

Beyond Molecular Structures: Investigating Demographic Factors in Drug-Induced Cardiotoxicity Prediction Models.

Journal of chemical information and modeling·2026
Same author

Simulation of fish chronic toxicity using the Las Vegas algorithm and the vector of ideality of correlation.

Environmental toxicology and chemistry·2026
Same author

QSAR in the AI Era: Reflections for Advancing Chemical Safety Assessment.

Chemical research in toxicology·2026

Related Experiment Video

Updated: Aug 9, 2025

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.0K

Principles and Procedures for Assessment of Acute Toxicity Incorporating In Silico Methods.

Craig M Zwickl1, Jessica Graham2, Robert Jolly3

  • 1Transendix LLC, Indianapolis, IN 46229, USA.

Computational Toxicology (Amsterdam, Netherlands)
|February 23, 2023
PubMed
Summary

In silico models now reliably predict acute toxicity (LD50) for GHS classification. A new framework integrates these with in vitro data for comprehensive hazard assessment.

More Related Videos

Lethality Bioassay Using Artemia salina L.
09:09

Lethality Bioassay Using Artemia salina L.

Published on: October 11, 2022

10.3K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.8K

Related Experiment Videos

Last Updated: Aug 9, 2025

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.0K
Lethality Bioassay Using Artemia salina L.
09:09

Lethality Bioassay Using Artemia salina L.

Published on: October 11, 2022

10.3K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.8K

Area of Science:

  • Toxicology
  • Computational Chemistry
  • Regulatory Science

Background:

  • Acute toxicity assessment is crucial for chemical safety across R&D, registration, and handling.
  • Current adoption of in silico models is limited by a lack of standardized guidance for analysis and documentation.
  • Existing methods often rely on LD50, prompting a need for more advanced, mechanism-based approaches.

Purpose of the Study:

  • To propose a framework for acute toxicity hazard assessment integrating in silico and in vitro/in vivo data.
  • To analyze the suitability of in silico methods for predicting in vivo outcomes like LD50.
  • To support the shift towards mechanism-based toxicity endpoints.

Main Methods:

  • Analysis of in silico methods for predicting LD50.
  • Overview of in vitro assay endpoints relevant to acute toxicity.
  • Development of a framework combining diverse data sources.
  • Application of weight-of-evidence considerations.

Main Results:

  • In silico predictions are well-suited for reliable LD50 assessment and GHS classification.
  • In vitro data and mechanistic understanding enable a move beyond LD50-centric evaluations.
  • The proposed framework effectively integrates various data types for hazard assessment.

Conclusions:

  • In silico models are valuable tools for acute toxicity assessment, particularly for GHS classification.
  • A comprehensive framework combining in silico, in vitro, and in vivo data, with expert review, enhances hazard assessment reliability.
  • The future of acute toxicity testing involves mechanism-based endpoints supported by computational and in vitro methods.